PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1

By Ghiotto Marguerite   Gauthier Laurent   Serriari Nacer   Pastor Sonia   Truneh Alemseged   Nuns Jacques A.   Olive Daniel  

International Immunology, Vol. 22, Iss. 8, 2010-05 ,pp. : 651-660

Oxford University Press

Access to resources Recommend Favorite

PD-1PD-L1 pathway impairs T h 1 immune response in the late stage of infection with Mycobacterium bovis bacillus CalmetteGurin

By Sakai Shunsuke   Kawamura Ikuo   Okazaki Taku   Tsuchiya Kohsuke   Uchiyama Ryousuke   Mitsuyama Masao  

International Immunology, Vol. 22, Iss. 12, 2010-12 ,pp. : 915-925

Oxford University Press

Access to resources Recommend Favorite

Intrahepatic PD-1/PD-L1 Up-regulation Closely Correlates with Inflammation and Virus Replication in Patients with Chronic HBV Infection

By Xie Zhunyi   Chen Yongwen   Zhao Songtao   Yang Zhiqing   Yao Xiaohong   Guo Sheng   Yang Chengying   Fei Lei   Zeng Xingguang   Ni Bing   Wu Yuzhang  

Immunological Investigations, Vol. 38, Iss. 7, 2009-10 ,pp. : 624-638

Informa Healthcare

Access to resources Recommend Favorite

Specific and high-affinity binding of tetramerized PD-L1 extracellular domain to PD-1-expressing cells: possible application to enhance T cell function

By Terawaki Seigo   Tanaka Yoshimasa   Nagakura Tomokazu   Hayashi Tamon   Shibayama Shiro   Muroi Kaori   Okazaki Taku   Mikami Bunzo   Garboczi David N.   Honjo Tasuku   Minato Nagahiro  

International Immunology, Vol. 19, Iss. 7, 2007-07 ,pp. : 881-890

Oxford University Press

Access to resources Recommend Favorite

PD-1 is a novel regulator of human B-cell activation

By Thibult Marie-Laure   Mamessier Emilie   Gertner-Dardenne Julie   Pastor Sonia   Just-Landi Sylvaine   Xerri Luc   Chetaille Bruno   Olive Daniel  

International Immunology, Vol. 25, Iss. 2, 2013-02 ,pp. : 129-137

Oxford University Press

Access to resources Recommend Favorite